Interleukin-6 increases thrombopoietin production in human hepatoma cells HepG2 and Hep3B

Journal of Interferon and Cytokine Research

Volumn 20, Issue 5, 2000, Pages 499-506

  Wolber, Eva Maria ^a   Jelkmann, Wolfgang ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; THROMBOPOIETIN;

ARTICLE; FIBROBLAST; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; THROMBOCYTOPOIESIS;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; DNA PRIMERS; HUMANS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; LIVER NEOPLASMS; RNA, MESSENGER; RNA, NEOPLASM; THROMBOCYTOSIS; THROMBOPOIETIN; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034082531     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/10799900050023915     Document Type: Article

References (41)

1. 1. KAUSHANSKY, K. (1997). Thrombopoietin: understanding and manipulating platelet production. Annu. Rev. Med. 48, 1-11.
2. 2. EATON, D.L., and DE SAUVAGE, F.J. (1997). Thrombopoietin: the primary regulator of megakaryocytopoiesis and thrombopoiesis. Exp. Hematol. 25, 1-7.
3. 3. COHEN-SOLAL, K., DEBILI, N., VAINCHENKER, W., and WENDLING, F. (1997). Thrombopoietin (mpl-ligand) and the regulation of platelet production. Thromb. Haemost. 78, 37-41.
4. 4. LOK, S., KAUSHANSKY, K., HOLLY, R.D., KUIJPER, J.L., LOFTON-DAY, C.E., OORT, P.J., GRANT, F.J., HEIPEL, M.D., BURKHEAD, S.K., KRAMER, J.M., BELL, A., SPRECHER, C.A., BLUMBERG, H., JOHNSON, R., PRUNKARD, D., CHING, A.F.T., MATHEWES, S.L., BAILEY, M.C., FORSTROM, J.W., BUDDLE, M.M., OSBORN, S.G., EVANS, S.J., SHEPPARD, P.O., PRESNELL, S.R., O'HARA, P.J., HAGEN, P.S., ROTH, G.J., and FOSTER, D.C. (1994). Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369, 565-568.
5. 5. McCARTY, J.M., SPRUGEL, K.H., FOX, N.E., SABATH, D.E., and KAUSHANSKY, K. (1995). Murine thrombopoietin mRNA levels are modulated by platelet count. Blood 86, 3668-3675.
6. 6. SUNGARAN, R., MARKOVIC, B., and CHONG, B.H. (1997). Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood 89, 101-107.
7. 7. DEBILI, N., WENDLING, F., COSMAN, D., TITEUX, M., FLORINDO, C., DUSANTER-FORT, I., SCHOOLEY, K., METHIA, N., CHARON, M., NADOR, R., BETTAIEB, A., and VAINCHENKER, W. (1995). The mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood 85, 391-401.
8. 8. FIELDER, P.J., GURNEY, A.L., STEFANICH, E., MARIAN, M., MOORE, M.W., CARVER-MOORE, K., and DE SAUVAGE, F.J. (1996). Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood 87, 2154-2161.
9. 9. NAGATA, Y., SHOZAKI, Y., NAGAHISA, H., NAGASAWA, T., ABE, T., and TODOKORO, K. (1997). Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis. Thromb. Haemost. 77, 808-814.
10. 10. HARRIES, A.D., FITZSIMONS, E., FIFIELD, R., DEW, M.J., and RHODES, J. (1983). Platelet count: a simple measure of activity in Crohn's disease. Br. Med. J. 286, 1476.
11. 11. SUTOR, A.H. (1995). Thrombocytosis in childhood. Semin. Thromb. Hemost. 21, 330-339.
12. 12. ESTROV, Z., TALPAZ, M., MAVLIGIT, G., PAZDUR, R., HARRIS, D., GREENBERG, S.M., and KURZROCK, R. (1995). Elevated plasma thrombopietic activity in patients with metastatic cancer-related thrombocytosis. Am. J. Med. 98, 551-558.
13. 13. CERUTTI, A., CUSTODI, P., DURANTI, M., NORIS, P., and BALDUINI, C.L. (1997). Thrombopoietin levels in patients with primary and reactive thrombocytosis. Br. J. Haematol. 99, 281-284.
14. 14. HEITS, F., KATSCHINSKI, D.M., WILMSEN, U., WIEDEMANN, G.J., and JELKMANN, W. (1997). Serum thrombopoietin and interleukin-6 concentrations in tumour patients and response to chemotherapy-induced thrombocytopenia. Eur. J. Haematol. 59, 53-58.
15. 15. WANG, J.C., CHEN, C., NOVETSKY, A.D., LICHTER, S.M., AHMED, F., and FRIEDBERG, N.M. (1998). Blood thrombopoietin levels in clonal thrombocytosis and reactive thrombocytosis. Am. J. Med. 104, 451-455.
16. 16. JELKMANN, W., PAGEL, H., WOLFF, M., and FANDREY, J. (1992). Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci. 50, 301-308.
17. 17. DETRISAC, C.J., SENS, M.A., GARVIN, A.J., SPICER, S.S., and SENS, D.A. (1984). Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int. 25, 383-390.
18. 18. KREFT, B., BRZOSKA, S., DOEHN, C., DAHA, M.R., VAN DER WOUDE, F.J., and SACK, K. (1996). 1,25-Dihydroxycholecalciferol enhances the expression of MHC class II antigens and intercellular adhesion molecule-1 by human renal tubular epithelial cells. J. Urol. 155, 1448-1453.
19. 19. STOLZE, B., EBELL, W., and WELTE, K. (1998). Different binding mechanisms of myeloid leukemic cells to adhesion molecules on bone marrow stromal fibroblasts induced by TNF-α and IL-4. Ann. Hematol. 77, 265-274.
20. 20. CHOMCZYNSKI, P., and SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
21. 21. SOHMA, Y., AKAHORI, H., SEKI, N., HORI, T., OGAMI, K., KATO, T., SHIMADA, Y., KAWAMURA, K., and MIYAZAKI, H. (1994). Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEES Lett. 353, 57-61.
22. 22. FANDREY, J., and BUNN, H.F. (1993). In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction. Blood 81, 617-623.
23. 23. WOLBER, E.M., DAME, C., FAHNENSTICH, H., HOFMANN, D., FÖDISCH, H.J., BARTMANN, P., JELKMANN, W., and FANDREY, J. (1999). Expression of the thrombopoietin gene in human fetal and neonatal tissues. Blood 94, 97-105.
24. 24. MARTIN, T.G., III, SOMBERG, K.A., MENG, Y.G., COHEN, R.L., HEID, C.A., DE SAUVAGE, F.J., and SHUMAN, M.A. (1997). Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann. Intern. Med. 127, 285-288.
25. 25. PECK-RADOSAVLJEVIC, M., WICHLAS, M., PIDLICH, J., SIMS, P., MENG, G., ZACHERL, J., GARG, S., DATZ, C., GANGL, A., and FERENCI, P. (1998). Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C. Hepatology 28, 1424-1429.
26. 26. HINO, M., NISHIZAWA, Y., TAGWA, S., YAMANE, T., MORII, H., and TATSUMI, N. (1995). Constitutive expression of the thrombopoietin gene in a human hepatoma cell line. Biochem. Biophys. Res. Commun. 217, 475-481.
27. 27. SHIMADA, Y., KATO, T., OGAMI, K., HORIE, K., KOKUBO, A., KUDO, Y., MAEDA, E., SOHMA, Y., AKAHORI, H., KAWAMURA, K., and MIYAZAKI, H. (1995). Production of thrombopoietin (TPO) by rat hepatocytes and hepatoma cell lines. Exp. Hematol. 23, 1388-1396.
28. 28. KNOWLES, B.B., HOWE, C.C., and ADEN, D.P. (1980). Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209, 497-499.
29. 29. KELLY, J.H., and DARLINGTON, G.J. (1989). Modulation of the liver specific phenotype in the human hepatoblastoma line HepG2. In Vitro Cell Dev. Biol. 25, 217-222.
30. 30. GOLDBERG, M.A., GLASS, G.A., CUNNINGHAM, J.M., and BUNN, H.F. (1987). The regulated expression of erythropoietin by two human hepatoma cell lines. Proc. Natl. Acad. Sci. USA 84, 7972-7976.
31. 31. NAGAHISA, H., NAGATA, Y., OHNUKI, T., OSADA, M., NAGASAWA, T., ABE, T., and TODOKORO, K. (1996). Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation. Blood 87, 1309-1316.
32. 32. GUERRIERO, A., WORFORD, L., HOLLAND, H.K., GUO, G.R., SHEEHAN, K., and WALLER, E.K. (1997). Thrombopoietin is synthesized by bone marrow stromal cells. Blood 90, 3444-3455.
33. 33. NAVARRO, S., DEBILI, N., LE COUEDIC, J.-P., KLEIN, B., BRETON-GORIUS, J., DOLY, J., and VAINCHENKER, W. (1991). Interleukin-6 and its receptor are expressed by human megakaryocytes: in vitro effects on proliferation and endoreplication. Blood 77, 461-471.
34. 34. BAATOUT, S. (1996). Interleukin-6 and megakaryocytopoiesis: an update. Ann. Hematol. 73, 157-162.
35. 35. HEINRICH, P.C., CASTELL, J.V., and ANDUS, T. (1990). Interleukin-6 and the acute-phase response. Biochem. J. 265, 621-636.
36. 36. FAQUIN, W.C., SCHNEIDER, T.J., and GOLDBERG, M.A. (1992). Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 79, 1987-1994.
37. 37. LENG, H.M.J., KIDSON, S.H., KERAAN, M.M., RANDALL, G.W., and FOLB, P.I. (1996). Cytokine-mediated inhibition of erythropoietin synthesis by dexamethasone. J. Pharm. Pharmacol. 48, 971-974.
38. 38. WENGER, R.H., MARTI, H.H., BAUER, C., and GASSMANN, M. (1998). Optimal erythropoietin expression in human hepatoma cell lines requires activation of multiple signalling pathways. Int. J. Mol. Med. 2, 317-324.
39. 39. KAMURA, T., HANDA, H., HAMASAKI, N., and KITAJIMA, S. (1997). Characterization of the human thrombopoietin gene promoter. J. Biol. Chem. 272, 11361-11368.
40. 40. STOFFEL, R., WIESTNER, A., and SKODA, R.C. (1996). Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 87, 567-573.
41. 41. COHEN-SOLAL, K., VILLEVAL, J.-L., TITEUX, M., LOK, S., VAINCHENKER, W., and WENDLING, F. (1996). Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis. Blood 88, 2578-2584.